To fuel its mission of redefining healthcare with a blend of expertise and data, Verras is seeking strategic partners, ...

NOVATO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) released its 2024 Impact ...

For the quarter ended March 31, 2025, the Company invested $104.7 million across 10 new portfolio companies and several follow-on revolver and delayed draw fundings. During this period, the Company ...

On May 14, 2025, the Board of Navigator Holdings Ltd., (NYSE: NVGS) ("Navigator Holdings,” "Navigator Gas," "our,” "we,” "us” or the "Company”) declared a cash dividend of $0.05 per share of the ...

ATHENS, Greece, May 14, 2025 (GLOBE NEWSWIRE) -- Okeanis Eco Tankers Corp. ("OET” or the "Company”) (NYSE: ECO / OSE: OET), announced today that the Company's board of directors (the "Board”) has ...

For the quarter ended March 31, 2025, Edesa reported a net loss of $1.6 million, or $0.30 per common share, compared to a net ...

Mr. Murray, who has served as an O-I director since 2015, was the Chief Executive Officer at Hanson PLC, which was acquired by HeidelbergCement AG in 2007, a German multinational building materials ...

Inception Growth Acquisition Limited (NASDAQ: IGTA, the 'Company”), a publicly traded special purpose acquisition company, announced today that on May 12, 2025, the Company deposited $11,199.60 into ...

Following completion of the dose escalation phase in relapsed/refractory acute leukemia patients with FLT3 mutations, Biomea ...

Dyadic International, Inc. ("Dyadic”, "we”, "us”, "our”, or the "Company”) (NASDAQ: DYAI), a biotechnology company specializing in the development of functional recombinant solutions and proprietary ...

Net revenue for the three months ended March 31, 2025, was approximately $0.3 million, reflecting sales of the QUELIMMUNE ...

Alumis received an upfront license fee of $20.0 million in March 2025 and will receive an additional $20.0 million in near-term co-development payments, with potential for additional milestone ...